The MBS review continues and appears to be on track to report by the end of the year. The review is looking at whether the 5,500 items on the Medical Benefits Schedule can be aligned with contemporary clinical evidence and improve health outcomes for Australians. This is an ambitious target as the process to list a single new procedure on the MBS via the Medical Services Advisory Committee (MSAC) can take up to 2 years. Some interesting issues have already emerged and are outlined in these excellent articles by Sean Parnel
Search website
Recent Posts
- The Prescribed List (formerly Prostheses List) Update – 2023. November 29, 2023
- 9th Annual Drugs & Devices Australia Webinar – 2023 November 3, 2023
- Recorded Webinar: The Prostheses List Reforms Update Webinar by MedTechnique Consulting August 2, 2023
- 8th Annual Drugs & Devices Australia – Reimbursement Update 2022 October 26, 2022
- AusMedtech 2022, 24-26 May May 3, 2022
Categories
- 2020 Medical Devices Outlook
- COVID-19
- Health and Government
- Health Insurance
- Medical Devices Reimbursement
- MedTechnique Consulting Newsletters
- MedTechnique Consulting Webinar
- MSAC
- MSAC Application Process for the Australian Market.
- New Technology
- The Prescribed List (Formerly Prostheses List) Australia
- Uncategorized
- Upcoming Medical Conferences